What Could Change After Staar Surgical Co (NASDAQ: STAA) Gains 21.01% From The High-Point?

Staar Surgical Co (NASDAQ:STAA)’s traded shares stood at 1.14 million during the last session, with the company’s beta value hitting 0.67. At the close of trading, the stock’s price was $17.09, to imply an increase of 3.01% or $0.5 in intraday trading. The STAA share’s 52-week high remains $52.68, putting it -208.25% down since that peak but still an impressive 21.01% since price per share fell to its 52-week low of $13.50.

Analysts have given a consensus recommendation of Buy for Staar Surgical Co (STAA), translating to a mean rating of 2.69. Of 13 analyst(s) looking at the stock, 1 analyst(s) give STAA a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 11 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.59.

Staar Surgical Co (NASDAQ:STAA) trade information

After registering a 3.01% upside in the last session, Staar Surgical Co (STAA) has traded red over the past five days. The 5-day price performance for the stock is -3.83%, and -30.50% over 30 days. With these gigs, the year-to-date price performance is -29.64%.

The extremes give us $45.03 and $85 for target low and target high price respectively. As such, STAA has been trading -397.37% off suggested target high and -163.49% from its likely low.

Staar Surgical Co (STAA) estimates and forecasts

The rating firms project that company’s revenue will shrink -16.93% compared to the previous financial year.

Revenue forecast for the current quarter as set by 11 analysts is 40.33M. Meanwhile, for the current quarter, a total of 11 analyst(s) estimate revenue growth to 41.1M.Earnings reports from the last fiscal year show that sales brought in 77.36M and 99M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -47.87% before dropping -58.49% in the following quarter.

STAA Dividends

Staar Surgical Co has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Staar Surgical Co (NASDAQ:STAA)’s Major holders

The next major institution holding the largest number of shares is BLACKROCK INC. with 7.49 million shares, or about 15.3123% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $356.54 million.